Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hiring Plans Are Central To US FDA's Digital Health Plan

Executive Summary

Hiring experts in artificial intelligence, cloud computing, cybersecurity and related fields is a central part of US FDA's recently announced "Digital Health Innovation Action Plan." The goal of the expanded team will be to make better regulatory decisions, issue new guidances and initiate a "pre-certification" pilot program for software.

Advertisement

Related Content

Senate Approves FDA User Fee Reauthorization Bill On 94-1 Vote
Software At The Speed Of Trust: US FDA Launches Pilot To Expedite Digital Health Products
US FDA's New Game Plan For Digital Health
US FDA Plan For Adopting International Software Guideline Draws Industry Concern
'Cures' Bill Circumvents FDA On Medical Software Regs
Next Step In Global Convergence: FDA Looks To Make IMDRF Software Guidance Its Own
CDRH Entrepreneurs Take Two: Streamlining Data Collection And The Path To Reimbursement

Topics

Advertisement
UsernamePublicRestriction

Register

MT105277

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel